Köhler, J., Zhao, Y., Li, J., Gokhale, P. C., Tiv, H. L., Knott, A. R., . . . Jänne, P. A. (2021). ERK inhibitor LY3214996-based treatment strategies for RAS-driven lung cancer. Mol Cancer Ther.
Style de citation ChicagoKöhler, Jens, et al. "ERK Inhibitor LY3214996-based Treatment Strategies for RAS-driven Lung Cancer." Mol Cancer Ther 2021.
Style de citation MLAKöhler, Jens, et al. "ERK Inhibitor LY3214996-based Treatment Strategies for RAS-driven Lung Cancer." Mol Cancer Ther 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.